Literature DB >> 23146882

Clinical and functional relevance of melanocortin-4 receptor variants in obese German children.

Christin Melchior1, Angela Schulz, Jan Windholz, Wieland Kiess, Torsten Schöneberg, Antje Körner.   

Abstract

BACKGROUND: Variants in the melanocortin-4 receptor (MC4R) gene are the most frequent cause of monogenic obesity. The relevance of MC4R variations with respect to clinical phenotype and biochemical function remains controversial.
METHODS: We sequenced the MC4R gene in 510 overweight/obese children. The clinical phenotype was assessed in a case-control setting matched for age, gender, puberty and body mass index. Identified MC4R variants were functionally characterized in vitro.
RESULTS: The frequency of MC4R variants was 5.3%, with functionally relevant mutations (D(90)N, V(103)I/S(127)L, R(165)W, G(181)D) occurring in 1.2% (confidence interval 0.26-2.15) of our sample. 4.1% were carriers of variants (Y(35)Y, V(103)I, T(112)M, M(200)V, I(251)L) with preserved receptor function in vitro. We did not detect large heterozygous deletions by multiple-ligand probe amplification assay. There were no differences in anthropometric or metabolic parameters between children with loss-of-function mutations and noncarriers. Carriers of the V(103)I or I(251)L variant had higher high-density lipoprotein cholesterol and HbA1c levels than matched noncarriers of MC4R variants.
CONCLUSIONS: In our data set of childhood obesity in central Germany, we identified functionally relevant mutations in the MC4R gene in only 1.2% of the children. There were no major significant phenotypic differences between obese children with and without MC4R mutations. Hence, the diagnosis of genetically caused obesity due to MC4R mutation should be made with caution.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146882     DOI: 10.1159/000343816

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  9 in total

1.  Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort.

Authors:  H Vollbach; S Brandt; G Lahr; C Denzer; J von Schnurbein; K-M Debatin; M Wabitsch
Journal:  Int J Obes (Lond)       Date:  2016-09-22       Impact factor: 5.095

2.  Melanocortin-4 Receptor Gene Mutations in a Group of Turkish Obese Children and Adolescents.

Authors:  Selma Tunç; Korcan Demir; Fatma Ajlan Tükün; Cihan Topal; Filiz Hazan; Burcu Sağlam; Özlem Nalbantoğlu; Melek Yıldız; Behzat Özkan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-02-20

3.  Genetic analysis of single-minded 1 gene in early-onset severely obese children and adolescents.

Authors:  Daniela Stanikova; Marek Buzga; Patrik Krumpolec; Martina Skopkova; Martina Surova; Barbara Ukropcova; Lubica Ticha; Miroslava Petrasova; Dominika Gabcova; Miroslava Huckova; Lucie Piskorova; Jan Bozensky; Marian Mokan; Jozef Ukropec; Ivona Zavacka; Iwar Klimes; Juraj Stanik; Daniela Gasperikova
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

4.  Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective.

Authors:  Nicolas Heyder; Gunnar Kleinau; Michal Szczepek; Dennis Kwiatkowski; David Speck; Lucia Soletto; José Miguel Cerdá-Reverter; Heiko Krude; Peter Kühnen; Heike Biebermann; Patrick Scheerer
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-31       Impact factor: 5.555

5.  Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.

Authors:  Sarah Paisdzior; Ioanna Maria Dimitriou; Paul Curtis Schöpe; Paolo Annibale; Patrick Scheerer; Heiko Krude; Martin J Lohse; Heike Biebermann; Peter Kühnen
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

6.  Identification of a Rare and Potential Pathogenic MC4R Variant in a Brazilian Patient With Adulthood-Onset Severe Obesity.

Authors:  Kaio Cezar Rodrigues Salum; Guilherme Orofino de Souza; Gabriella de Medeiros Abreu; Mário Campos Junior; Fabiana Barzotto Kohlrausch; João Regis Ivar Carneiro; José Firmino Nogueira Neto; Fernanda Cristina C Mattos Magno; Eliane Lopes Rosado; Lohanna Palhinha; Clarissa Menezes Maya-Monteiro; Giselda Maria Kalil de Cabello; Pedro Hernán Cabello; Patrícia Torres Bozza; Verônica Marques Zembrzuski; Ana Carolina Proença da Fonseca
Journal:  Front Genet       Date:  2020-12-09       Impact factor: 4.599

Review 7.  The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits.

Authors:  Anke Hinney; Antje Körner; Pamela Fischer-Posovszky
Journal:  Nat Rev Endocrinol       Date:  2022-07-28       Impact factor: 47.564

8.  Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations.

Authors:  Cæcilie Trier; Mette Hollensted; Theresia M Schnurr; Morten Asp Vonsild Lund; Tenna Ruest Haarmark Nielsen; Gao Rui; Ehm Astrid Andersson; Mathilde Svendstrup; Dorthe Sadowa Bille; Anette P Gjesing; Cilius Esmann Fonvig; Christine Frithioff-Bøjsøe; Marie Balslev-Harder; Shi Quan; Michael Gamborg; Oluf Pedersen; Lars Ängquist; Jens-Christian Holm; Torben Hansen
Journal:  Int J Obes (Lond)       Date:  2020-09-13       Impact factor: 5.095

9.  Identification of novel LEPR mutations in Pakistani families with morbid childhood obesity.

Authors:  Robina Khan Niazi; Anette P Gjesing; Mette Hollensted; Christian Theil Have; Niels Grarup; Oluf Pedersen; Asmat Ullah; Gulbin Shahid; Wasim Ahmad; Asma Gul; Torben Hansen
Journal:  BMC Med Genet       Date:  2018-11-15       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.